American Fusion(TM) Inc. (AMFN) Expands North Texas

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
64
American Fusion(TM) Inc. (AMFN) Expands North Texas Operations as Texatron(TM) Testing and Patent Activity Advance


- The company is relocating its headquarters to the Fort Worth metropolitan area as it expands engineering, laboratory, and fabrication operations.

- The new facility is intended to consolidate engineering, manufacturing and administrative functions under one roof.

- The company is progressing toward a testing agreement with Texas Tech University for both its 5MW and 500kW Texatron(TM) Fusion Engine(TM) platforms.

- Management expects university testing infrastructure to accelerate portions of its development program, with initial testing activities targeted as early as July.

- Seven additional U.S. patent applications were filed to expand intellectual property surrounding the Texatron(TM) Fusion Engine(TM) architecture.

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, has announced a series of operational and technology milestones as it advances development of its Texatron(TM) Fusion Engine(TM) platform, highlighting a headquarters relocation to the Fort Worth area, progress toward a university testing agreement, and continued expansion of its intellectual property portfolio. The updates, announced July 1, reflect several parallel initiatives intended to support the company’s long-term commercialization strategy (https://nnw.fm/gUaDa).

The company said it is relocating its operations from Midland, Texas, to the Fort Worth metropolitan area, where engineering, fabrication, laboratory and administrative functions will ultimately operate from a single integrated facility. According to management, the move will occur in two stages. Engineering and administrative personnel are initially relocating into temporary facilities adjacent to the permanent headquarters while construction of the company’s dedicated engineering shop and laboratory is completed. American Fusion(TM) expects the permanent facility to become operational within approximately one month.

Executive Chairman Brent Nelson said consolidating the company’s technical and executive teams under one roof is expected to improve collaboration and streamline development activities as work progresses on the Texatron(TM) Fusion Engine(TM) platform.

Alongside the relocation, American Fusion(TM) reported continued progress toward finalizing definitive agreements with Texas Tech University for access to specialized testing facilities. The proposed arrangement would provide infrastructure for evaluating both the company’s new 5-megawatt Texatron(TM) Fusion Engine(TM) and conducting additional testing on its existing 500-kilowatt platform.

Management believes utilizing established university research facilities could accelerate portions of the testing schedule while providing opportunities to collaborate with experienced scientific and technical personnel. According to the company, discussions continue to advance toward final agreements, with initial testing activities potentially beginning as early as July if current timelines remain on schedule.

Chief Technology Officer Dr. John E. Brandenburg said combining the new North Texas engineering operations with access to specialized testing infrastructure could streamline the company’s development program as both internal and external capabilities expand.

The announcement also highlighted continued investment in intellectual property protection, another important consideration for companies developing emerging technologies. Between June 26 and June 30, American Fusion(TM) filed seven additional U.S. patent applications covering various aspects of its proprietary Texatron(TM) Fusion Engine(TM) platform.

Collectively, the filings describe technical concepts involving fusion confinement architecture, hollow toroidal chamber designs, rifled interior surfaces, electromagnetic field generation and related system configurations. The applications include both clam-shell and unitary confinement device designs, as well as methods intended to generate what the company describes as an electromagnetic foil within portions of the confinement system.

As with any patent application, the filings remain subject to examination by the United States Patent and Trademark Office, and there can be no assurance that any application will ultimately mature into an issued patent or that any resulting claims will receive the scope currently sought by the company. Nevertheless, management views continued patent activity as an important component of its commercialization strategy.

Chief Legal Officer Michael G. Smith noted that each filing represents extensive engineering analysis, technical documentation and legal review designed to strengthen the company’s growing intellectual property portfolio around the Texatron(TM) platform.

The latest patent applications build upon American Fusion’s(TM) broader strategy of protecting multiple aspects of its fusion technology while continuing engineering development in parallel.

American Fusion(TM) operates through its wholly owned subsidiary, Kepler Fusion Technologies, which is responsible for developing the Texatron(TM) fusion platform. Following its previously announced merger with Kepler, the company adopted the American Fusion(TM) name as it shifted its focus toward advancing fusion energy technologies.

The Texatron(TM) Fusion Engine(TM) is being developed as an aneutronic fusion platform intended for modular deployment across industrial, commercial, defense and grid-constrained energy applications. The company’s strategy emphasizes system-level engineering, scalable architecture and disciplined capital allocation while building an intellectual property portfolio designed to support future commercialization.

Fusion energy remains an emerging field attracting increasing interest from both public and private investors because of its potential to produce large amounts of energy with lower emissions than conventional fossil fuels. However, commercial deployment across the broader industry remains technically challenging, requiring significant advances in plasma confinement, engineering reliability and manufacturing scalability.

Against that backdrop, American Fusion’s(TM) latest announcement illustrates the practical steps many early-stage energy technology companies must take as development progresses, from expanding engineering infrastructure and establishing external research partnerships to protecting proprietary designs through patent filings.

For more information, visit the company’s website at www.AmericanFusionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to AMFN are available in the company’s newsroom at https://nnw.fm/AMFN

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer

American Fusion Inc (AMFN) Stock Research Links

AMFN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 9

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 17

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 15

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 7

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 7

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 9

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 12

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Upcoming Earnings Announcements and Market Insights

Updated Category News Views 249

Companies Reporting Earnings Before The Market Opens Various companies are preparing for their quarterly earnings reports, each with expectations that could impact their stock performance in the market. For example, Bank of Hawaii is anticipated to report quarterly earnings of $1.05 per share on revenue of approximately $174.39 million. Similarly, Business First...

Continue Reading
Bloom Nutrition Unveils Bloom Pop: A Healthier Soda Choice

Updated Category News Views 425

Bloom Nutrition Introduces Bloom Pop Bloom Nutrition, the brand known for revolutionizing the wellness industry, has launched an exciting new product called Bloom Pop. This innovative soda is now available exclusively at Walmart, marking a significant step in the brand's journey towards making healthier options fun and accessible. A Bold and Bubbly Innovation Bloom Pop...

Continue Reading
Renault Surpasses Stellantis in European Car Market Growth

Updated Category News Views 502

Renault's Growth in the European Car Market Recent statistics reveal that new car sales in Europe showed a modest increase of 0.9% in 2024, primarily driven by a significant rise in hybrid vehicle registrations. This surge marks the fourth consecutive month where hybrid sales have surpassed those of petrol vehicles, indicating a pivotal shift in consumer preferences....

Continue Reading
Market Reactions Following Intense Presidential Debate Showdown

Updated Category News Views 91

Markets React to the Presidential Debate U.S. stock futures slipped and the dollar softened as investors watched a heated presidential debate reshape the political conversation. It was the first direct face-off between Republican candidate Donald Trump and Democratic Vice President Kamala Harris. Early reads from traders and analysts suggested Harris may have had the...

Continue Reading
Eli Lilly's Kisunla Gains Approval for Alzheimer's Treatment in UK

Updated Category News Views 81

Eli Lilly's Kisunla Gains Approval for Alzheimer's Treatment in the UK Eli Lilly and Company has recently celebrated a significant milestone with the approval of their innovative treatment, Kisunla™ (donanemab-azbt), for mild cognitive impairment and mild dementia associated with Alzheimer's disease. This groundbreaking therapy is specifically designed for adult...

Continue Reading